Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Leukemia (67)
Bone Marrow Transplantation (42)
British Journal of Cancer (26)
Blood Cancer Journal (9)
Nature (4)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (113)
Reviews (19)
Correspondence (18)
Amendments and Corrections (4)
News (1)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Biological techniques
Biomarkers
Biotechnology
Cancer
Cell biology
Chemical biology
Computational biology and bioinformatics
Developmental biology
Diseases
Drug discovery
Genetics
Health care
Immunology
Medical research
Oncology
Pathogenesis
Risk factors
Stem cells

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–50 of 155 results

Advanced filters: Author: B. Barlogie Clear advanced filters

Long-term follow-up after high-dose therapy for high-risk multiple myeloma

B Barlogie
S Jagannath
R Alexanian
Research18 May 1998
Bone Marrow Transplantation

Volume: 21, P: 1101-1107
A potential role for Dkk-1 in the pathogenesis of osteosarcoma predicts novel diagnostic and treatment strategies.

Carl Gregory
Narae Lee
Edwin Horwitz
ResearchOpen Access21 Jun 2007
Nature Precedings

P: 1
Comparison of marrow vs blood-derived stem cells for autografting in previously untreated multiple myeloma

N Raje
R Powles
J Treleaven
Research01 Jun 1997
British Journal of Cancer

Volume: 75, P: 1684-1689
Identification and quantitation of tumour cells in cell suspensions: a comparison of cytology and flow cytometry

D J Perez
I W Taylor
M H Tattersall
Research01 Apr 1981
British Journal of Cancer

Volume: 43, P: 526-531
High-dose chemotherapy with carboplatin, cyclophosphamide and etoposide and autologous transplantation for multiple myeloma relapsing after a previous transplant

J Mehta
G Tricot
B Barlogie
Research01 Jul 1997
Bone Marrow Transplantation

Volume: 20, P: 113-116
Bolus vincristine and epirubicin with cyclophosphamide and dexamethasone (VECD) as induction and salvage treatment in multiple myeloma

A Fosså
M Muer
MR Nowrousian
Research30 Apr 1998
Leukemia

Volume: 12, P: 422-426
Salvage autologous or allogeneic transplantation for multiple myeloma refractory to or relapsing after a first-line autograft?

J Mehta
G Tricot
B Barlogie
Research23 Apr 1998
Bone Marrow Transplantation

Volume: 21, P: 887-892
Sequential analysis of bone marrow and peripheral blood after stem cell transplant for myeloma shows disparate tumor involvement

D Billadeau
F Prosper
B Van Ness
Research01 Sept 1997
Leukemia

Volume: 11, P: 1565-1570
Analysis of p73 and p53 gene deletions in multiple myeloma

B Schultheis
A Krämer
R Hehlmann
Research02 Dec 1999
Leukemia

Volume: 13, P: 2099-2103
An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma

I Hus
A Dmoszynska
J Kloczko
ResearchOpen Access02 Nov 2004
British Journal of Cancer

Volume: 91, P: 1873-1879
Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma

HM Lokhorst
P Sonneveld
PW Wijermans
Research12 Feb 1999
Bone Marrow Transplantation

Volume: 23, P: 317-322
Hypodiploidy, Ki-67 growth fraction and prognosis of surgically resected lung cancers

J-L Pujol
J Simony
F-B Michel
Research01 Sept 1996
British Journal of Cancer

Volume: 74, P: 964-970
Feasibility and cost-effectiveness of outpatient autotransplants in multiple myeloma

S Jagannath
DH Vesole
B Barlogie
Research01 Sept 1997
Bone Marrow Transplantation

Volume: 20, P: 445-450
Reduced progression-free survival in elderly patients receiving intensification with autologous peripheral blood stem cell reinfusion for multiple myeloma

C Dumontet
N Ketterer
B Coiffier
Research14 May 1998
Bone Marrow Transplantation

Volume: 21, P: 1037-1041
Melphalan 220 mg/m² followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma

P Moreau
N Milpied
J-L Harousseau
Research25 May 1999
Bone Marrow Transplantation

Volume: 23, P: 1003-1006
Corrigendum: Iridium in Mississippi River suspended matter and Gulf of Mexico sediment

F. D. Fenner
B. J. Presley
Research31 Jan 1985
Nature

Volume: 313, P: 406
Glomerular filtration rate prior to high-dose melphalan 200 mg/m²as a surrogate marker of outcome in patients with myeloma

B Sirohi
R Powles
J Treleaven
ResearchOpen Access31 Jul 2001
British Journal of Cancer

Volume: 85, P: 325-332
Autologous transplantation of mobilized peripheral blood CD34⁺ cells selected by immunomagnetic procedures in patients with multiple myeloma

R Abonour
KM Scott
K Cornetta
Research20 Nov 1998
Bone Marrow Transplantation

Volume: 22, P: 957-963
Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatment

R Powles
N Raje
J Treleaven
Research01 Sept 1997
Bone Marrow Transplantation

Volume: 20, P: 435-443
Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry

A Alegre
J Díaz-Mediavilla
JM Fernández-Rañada
Research18 Feb 1998
Bone Marrow Transplantation

Volume: 21, P: 133-140
Transbilayer disposition of the phospholipid annulus surrounding a calcium transport protein

J. P. BENNETT
K. A. McGILL
G. B. WARREN
Research24 Aug 1978
Nature

Volume: 274, P: 823-825
Autologous CD34-selected blood progenitor cell transplants for patients with advanced multiple myeloma

G Schiller
R Vescio
J Berenson
Research18 Feb 1998
Bone Marrow Transplantation

Volume: 21, P: 141-145
Interphase FISH: a rapid method for detecting malignant plasma cells in multiple myeloma patients submitted to autologous transplantation

C M Dascalescu
M Callanan
D Leroux
Research23 Mar 1999
Bone Marrow Transplantation

Volume: 23, P: 687-694
Activation and repression of transcription by homoeodomain-containing proteins that bind a common site

James B. Jaynes
Patrick H. O'Farrell
Research29 Dec 1988
Nature

Volume: 336, P: 744-749
Multicyclic, dose-intensive chemotherapy supported by hemopoietic progenitors in refractory myeloma patients

A Palumbo
A Pileri
M Boccadoro
Research01 Jan 1997
Bone Marrow Transplantation

Volume: 19, P: 23-29
Ras oncogene expression and DNA content in plasma cell dyscrasias: a flow cytofluorimetric study

M Danova
A Riccardi
G Mazzini
Research01 Nov 1990
British Journal of Cancer

Volume: 62, P: 781-785
High-dose cytosine arabinoside (Ara-C) in colorectal cancer

M Kanojia
H Kantarjian
B Barlogie
Research01 Dec 1983
British Journal of Cancer

Volume: 48, P: 869-871
Peripheral stem cell mobilization and engraftment in patients over age 60

SC Guba
DH Vesole
G Tricot
Research01 Jul 1997
Bone Marrow Transplantation

Volume: 20, P: 1-3
High levels of circulating CD34+ cells at autologous stem cell collection are associated with favourable prognosis in multiple myeloma

J Raschle
D Ratschiller
T Pabst
ResearchOpen Access30 Aug 2011
British Journal of Cancer

Volume: 105, P: 970-974
Use of coupled transcription and translation to study mRNA production by vaccinia cores

HUGH R. B. PELHAM
Research01 Oct 1977
Nature

Volume: 269, P: 532-534
VTD combination therapy with bortezomib–thalidomide–dexamethasone is highly effective in advanced and refractory multiple myeloma

M Pineda-Roman
M Zangari
B Barlogie
Research24 Apr 2008
Leukemia

Volume: 22, P: 1419-1427
Collection of peripheral blood stem cells after a preceding autograft: unfavorable effect of prior interferon-α therapy

S Singhal
J Mehta
B Barlogie
Research23 Jul 1999
Bone Marrow Transplantation

Volume: 24, P: 13-17
Long-term results (12 years) of high-dose therapy in 127 patients with de novo multiple myeloma

P Moreau
R Misbahi
JL Harousseau
Research30 Aug 2002
Leukemia

Volume: 16, P: 1838-1843
Induction of interleukin-6 (IL-6) autoantibodies through vaccination with an engineered IL-6 receptor antagonist

Laura Ciapponi
Domenico Maione
Rocco Savino
Research01 Oct 1997
Nature Biotechnology

Volume: 15, P: 997-1001
Novel targeted drugs for the treatment of multiple myeloma: from bench to bedside

B Bruno
L Giaccone
M Boccadoro
Reviews11 Aug 2005
Leukemia

Volume: 19, P: 1729-1738
Complex karyotypes in flow cytometrically DNA-diploid squamous cell carcinomas of the head and neck

J Åkervall
Y Jin
J Wennerberg
Research01 Apr 1998
British Journal of Cancer

Volume: 77, P: 1082-1088
The effect of hyperthermia in combination with melphalan on drug-sensitive and drug-resistant CHO cells in vitro

DA Bates
WJ Mackillop
Research01 Aug 1990
British Journal of Cancer

Volume: 62, P: 183-188
Human myeloid leukaemic cell interactions in vitro with normal myeloid colonies

G Spitzer
D S Verma
S Tindle
Research01 Feb 1981
British Journal of Cancer

Volume: 43, P: 149-156
Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis

A Seckinger
T Meißner
D Hose
Research31 Aug 2009
Oncogene

Volume: 28, P: 3866-3879
Breast cancer proliferation measured on cytological samples: a study by flow cytometry of S-phase fractions and BrdU incorporation

Y Remvikos
P Vielh
H Magdelénat
Research01 Sept 1991
British Journal of Cancer

Volume: 64, P: 501-507
Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myeloma

The prognosis of multiple myeloma patients varies widely. Here, to identify genetic factors associated with differing prognoses, the authors carried out a meta-analysis of four genome-wide association studies and identified a risk variant associated with survival interval.

David C. Johnson
Niels Weinhold
Gareth J. Morgan
ResearchOpen Access08 Jan 2016
Nature Communications

Volume: 7, P: 1-7
Long-term results of intrathoracic chemohyperthermia (ITCH) for the treatment of pleural malignancies

O Monneuse
A C Beaujard
O Glehen
ResearchOpen Access10 Jun 2003
British Journal of Cancer

Volume: 88, P: 1839-1843
CR represents an early index of potential long survival in multiple myeloma

M Wang
K Delasalle
R Alexanian
Research27 Jul 2009
Bone Marrow Transplantation

Volume: 45, P: 498-504
Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis

Giovanni Palladini
Bruno Paiva
Giampaolo Merlini
ResearchOpen Access16 Feb 2021
Blood Cancer Journal

Volume: 11, P: 1-7
The evolving background for high-dose treatment for myeloma

B Sirohi
R Powles
K C Anderson
Reviews01 Oct 2007
Bone Marrow Transplantation

Volume: 40, P: 1097-1100
Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

In multiple myeloma, malignant cells expand within bone marrow. Here, the authors use multi-region sequencing in patient samples to analyse spatial clonal architecture and heterogeneity, providing novel insight into multiple myeloma progression and evolution.

L. Rasche
S. S. Chavan
N. Weinhold
ResearchOpen Access16 Aug 2017
Nature Communications

Volume: 8, P: 1-11
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project

Saad Z. Usmani
Antje Hoering
Philippe Moreau
ResearchOpen Access23 Nov 2018
Blood Cancer Journal

Volume: 8, P: 1-7
The relationship between cisplatin sensitivity and drug uptake into mammalian cells in vitro

H Eichholtz-Wirth
B Hietel
Research01 Aug 1986
British Journal of Cancer

Volume: 54, P: 239-243
Erratum: International uniform response criteria for multiple myeloma

B G M Durie
J-L Harousseau
G Morgan
Amendments and Corrections22 Nov 2006
Leukemia

Volume: 20, P: 2220
Serum thymidine kinase in acute leukaemia

H Hagberg
S Gronowitz
G Öberg
Research01 Apr 1984
British Journal of Cancer

Volume: 49, P: 537-540

Previous page
page 1
page 2
page 3
page 4
Next page

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

© 2026 Springer Nature Limited